Vertex Posts Wider Loss
Vertex(VRTX Quote) reported a wider loss after the market close Monday as it steps away from research-based collaborations and funnels more money into its midstage program for Hepatitis C drug telaprevir.
The Cambridge, Mass.-based company reported a net loss of $107 million, or 82 cents a share, for the quarter, compared to a loss of $51.8 million, or 46 cents a share, in the year-ago quarter. Before items, the company reported a loss of $93.2 million, or 72 cents a share, compared to a loss of $47.9 million, or 42 cents a share, in the year-ago quarter. Analysts polled by Thomson Financial were anticipating a loss of 73 cents.
Vertex said revenue for the quarter was $41 million, compared to $53.3 million in the year-ago period, attributing the drop to a loss of revenue from research-based collaborations. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,291.86 | 1,093.59 | 2,179.79 | 33.86 |
Oil *
75.60
|
|
DOWN
98.25
|
DOWN
9.66
|
DOWN
9.82
|
DOWN
0.62
|
10 Yr
3.39%
SPDR Gold
112.26
|
|
-0.95%
|
-0.88%
|
-0.45%
|
-1.80%
|
Data delayed 20 minutes |
Connect with TheStreet